Cyramza 500 mg/50 mL (10 mg/mL) injection Images
Generic Name: ramucirumab
This medication has been identified as Cyramza 500 mg/50 mL (10 mg/mL) injection. It is supplied by Eli Lilly and Company.
Cyramza is used in the treatment of Non Small Cell Lung Cancer; Gastric Cancer; Stomach Cancer; Colorectal Cancer; Hepatocellular Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Cyramza 500 mg/50 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Cyramza
- Generic Name
- ramucirumab
- Strength
- 500 mg/50 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-7678
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
More about Cyramza (ramucirumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.